News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Saturday, June 10, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From Medscape Neurology

      Coverage from the

      7th Joint European Committee for Treatment and Research in Multiple Sclerosis-Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS-ACTRIMS) 2017

      October 25 - 28, 2017; Paris, France

      October 25 - 28, 2017 Paris, France
      • ECTRIMS Ibudilast 'Impressive' for Progressive MS in Phase 2 Trial The novel small-molecule drug ibudilast was associated with a 48% reduction in brain atrophy progression and 'excellent tolerability,' meeting both primary outcomes in the phase 2 SPRINT-MS trial.
        Medscape Medical News, October 30, 2017
      • ECTRIMS European MS Treatment Guidelines Released The first real guidelines on the use of disease-modifying therapies cover the treatment of adults with MS or CIS, the monitoring of treatment response, the stopping and switching of treatment strategies, and treatment in special situation, such as pregnancy.
        Medscape Medical News, October 27, 2017
      • ECTRIMS New MS Diagnostic Criteria Will Allow Earlier Diagnosis The updated McDonald criteria allow CSF findings and symptomatic MRI lesions to be considered for the diagnosis of multiple sclerosis.
        Medscape Medical News, October 27, 2017

      Conference News

      Popular News from ECTRIMS 2016

      • New Draft MS Treatment Guidelines in US and Europe New Draft MS Treatment Guidelines in US and Europe New guidelines for the treatment of multiple sclerosis are being drawn up in both Europe and the United States, with initial drafts having been released in the past few days.
        Medscape Medical News, Sep 21, 2016
      • Blood Test for Multiple Sclerosis? Blood Test for Multiple Sclerosis? The IQIsolate system identifies diagnostic gene expression patterns consistent with multiple sclerosis in peripheral whole blood samples with 90% accuracy, report investigators.
        Medscape Medical News, Oct 7, 2016
      • OTC Supplement May Reduce Brain Atrophy in SPMS OTC Supplement May Reduce Brain Atrophy in SPMS Although the pilot trial was small, its finding of a 66% reduction rate in whole-brain atrophy with lipoic acid, an over-the-counter supplement, vs placebo is grabbing attention. 'It looks very encouraging,' said one expert.
        Medscape Medical News, Sep 23, 2016

      Medscape Neurology©  WebMD, LLC

      Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

      ECTRIMS on Twitter

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.